Dermatologist and hair loss — understanding when and how to seek specialist care can be the difference between reversible and permanent hair loss. Hair shedding affects people of all ages, but not all types of alopecia are the same, and accurate diagnosis is essential before any treatment begins. From androgenetic alopecia and alopecia areata to scarring conditions requiring urgent intervention, a consultant dermatologist offers the expertise to identify the cause and tailor a management plan. This guide covers when to seek a referral, what to expect at your appointment, and the treatment options available through NHS and private dermatology services in the UK.

When Should You See a Dermatologist for Hair Loss?

See a dermatologist if you experience sudden or patchy hair loss, scalp symptoms such as itching, redness or pain, or progressive thinning — particularly if scarring alopecia is suspected, as delay can result in permanent hair loss.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss is a common concern affecting people of all ages and backgrounds, but knowing when to seek specialist input can make a significant difference to outcomes. Some daily hair shedding is entirely normal; seek advice if you notice more shedding or thinning than usual, rather than focusing on a specific number of hairs lost.

You should consider seeking a dermatological opinion if you notice:

• Sudden or rapid hair loss over a period of weeks

• Patchy bald areas appearing on the scalp or elsewhere on the body

• Scalp symptoms such as persistent itching, redness, scaling, pain, or a burning sensation — which may suggest scarring alopecia requiring prompt assessment

• Diffuse thinning over the crown or widening of the hair parting, particularly in women (hairline recession in women may suggest a different diagnosis, such as frontal fibrosing alopecia)

• Hair loss following a significant illness, surgery, or major psychological stress

• Children with patchy hair loss, scalp scaling, or broken hairs, which may indicate tinea capitis (scalp ringworm) and warrants prompt assessment

It is advisable to first consult your GP, who can rule out underlying medical causes such as thyroid dysfunction, iron deficiency anaemia, or hormonal imbalances. If initial investigations are inconclusive or the hair loss is progressive, a referral to a dermatologist is appropriate. Early specialist review is particularly important when scarring alopecia is suspected, as this form of hair loss can be irreversible if not treated promptly. Equally, if hair loss is causing significant psychological distress — which is well recognised in clinical literature — this alone is a valid reason to seek further support and specialist assessment.

Further information: NHS – Hair loss (alopecia); British Association of Dermatologists (BAD) patient leaflets on female-pattern hair loss, frontal fibrosing alopecia, and scarring alopecias.

How Dermatologists Diagnose the Cause of Hair Loss

Dermatologists diagnose hair loss using clinical examination, trichoscopy, targeted blood tests, and scalp biopsy when required, ensuring treatment is directed at the confirmed underlying cause rather than prescribed empirically.

Accurate diagnosis is the cornerstone of effective hair loss management. Dermatologists use a combination of clinical examination, patient history, and targeted investigations to identify the underlying cause. The diagnostic process is thorough and tailored to the individual, as hair loss has numerous potential aetiologies.

During the clinical assessment, the dermatologist will evaluate:

• The pattern and distribution of hair loss across the scalp and body

• Scalp condition, including signs of inflammation, scarring, or follicular changes

• Hair shaft characteristics, such as breakage, texture changes, or miniaturisation

• Associated symptoms, including nail changes or skin involvement elsewhere

A simple hair pull test may be performed at the bedside to assess active shedding. Trichoscopy (dermoscopy of the scalp) is a non-invasive tool increasingly used in specialist practice, allowing magnified visualisation of the hair follicles and scalp surface and helping to differentiate conditions such as androgenetic alopecia from alopecia areata or lichen planopilaris.

Blood tests are commonly requested to exclude systemic causes. These typically include a full blood count, ferritin, and thyroid function tests. Hormonal profiles (such as androgen levels) are generally reserved for women who have clinical features suggesting hyperandrogenism — for example, hirsutism, acne, or menstrual irregularity — rather than being performed routinely in all cases of diffuse hair loss, in line with UK primary care guidance.

Tinea capitis is primarily a clinical diagnosis, supported by mycological sampling (scalp scraping or hair plucking for culture); scalp biopsy is not routinely required. In other cases, a scalp biopsy performed under local anaesthetic may be used to obtain a definitive histological diagnosis, particularly when scarring alopecia is suspected or the diagnosis remains uncertain after other investigations. This level of investigation ensures that treatment is appropriately targeted rather than empirical, improving the likelihood of a meaningful clinical response.

Further information: NICE CKS – Alopecia areata; NICE CKS – Male pattern hair loss; NICE CKS – Tinea capitis; BAD patient leaflets (Alopecia areata; Telogen effluvium).

Common Types of Hair Loss a Dermatologist Can Treat

Dermatologists treat a wide range of conditions including androgenetic alopecia, alopecia areata, telogen effluvium, scarring alopecias, tinea capitis, traction alopecia, and trichotillomania, each requiring a distinct management approach.

Dermatologists are trained to manage a wide spectrum of hair loss conditions, ranging from self-limiting to chronic and complex. Understanding the type of alopecia is essential, as each has a distinct mechanism and treatment approach.

Androgenetic alopecia (male- or female-pattern hair loss) is the most prevalent form, driven by genetic sensitivity to dihydrotestosterone (DHT). In men, it typically presents as gradual thinning at the crown and temples. In women, it more commonly causes diffuse thinning over the crown with widening of the hair parting, usually with preservation of the frontal hairline.

Alopecia areata is an autoimmune condition in which the immune system mistakenly targets hair follicles, causing patchy, non-scarring hair loss. It can progress to alopecia totalis (complete scalp hair loss) or alopecia universalis (loss of all body hair) in some individuals.

Telogen effluvium is a reactive, diffuse shedding that typically begins two to three months after a physiological stressor — such as childbirth, severe illness, nutritional deficiency, or significant weight loss. Acute telogen effluvium usually resolves spontaneously over several months once the trigger is addressed; a chronic form also exists and may require further investigation.

Scarring alopecias, including lichen planopilaris, frontal fibrosing alopecia, and central centrifugal cicatricial alopecia (CCCA — more prevalent in people of African ancestry), involve permanent destruction of hair follicles due to inflammation. These require prompt treatment to halt progression, as hair loss in affected areas is irreversible.

Other conditions managed by dermatologists include tinea capitis (fungal scalp infection, more common in children), which is contagious and generally requires systemic antifungal treatment alongside contact management in line with UK guidance; traction alopecia caused by hairstyling practices; and trichotillomania, a hair-pulling disorder that may require a multidisciplinary approach involving psychological support alongside dermatological care.

Further information: NHS – Alopecia areata; NHS – Scalp ringworm (tinea capitis); BAD patient leaflets (Lichen planopilaris; Frontal fibrosing alopecia; Traction alopecia; Tinea capitis).

Treatment Options Available Through NHS and Private Dermatology

Treatment options range from licensed medicines such as minoxidil, finasteride, and JAK inhibitors to specialist procedures; not all treatments are NHS-funded, and some — including oral minoxidil for hair loss — are used off-label under specialist supervision.

Treatment for hair loss varies considerably depending on the underlying diagnosis, and options are available through both NHS and private dermatology services. Not all treatments are available on the NHS, particularly those considered primarily cosmetic.

Pharmacological treatments commonly used include:

• Minoxidil (topical): Licensed in the UK for androgenetic alopecia. Available over the counter. Common side effects include scalp irritation and unwanted facial hair growth. It should be avoided during pregnancy and breastfeeding unless a specialist advises otherwise. Consult a pharmacist or clinician before use if you have cardiovascular conditions.

• Minoxidil (oral): Oral minoxidil tablets are licensed in the UK for hypertension (brand name Loniten), not for hair loss. Their use for hair loss is therefore off-label and should only be initiated and monitored by a specialist. Potential side effects include hypertrichosis (unwanted hair growth), fluid retention, oedema, tachycardia, hypotension, and, rarely, pericardial effusion. It is not recommended during pregnancy or breastfeeding.

• Finasteride (oral, for men): A 5-alpha reductase inhibitor that reduces DHT levels, licensed for male-pattern hair loss. It is contraindicated in women of childbearing potential due to teratogenic risk; women who are pregnant or may become pregnant should not handle crushed or broken tablets. The MHRA has issued safety warnings regarding an association with depression, suicidal thoughts, and sexual dysfunction (including reduced libido, erectile dysfunction, and ejaculatory disorders), which may persist after stopping the medicine. Finasteride can also reduce PSA levels, which should be taken into account when interpreting prostate cancer screening results. Patients should be counselled about these risks before starting treatment.

• Corticosteroids: Used in alopecia areata and inflammatory alopecias, administered topically, by intralesional injection, or systemically depending on severity.

• Immunotherapy (diphencyprone): A specialist treatment for extensive alopecia areata, available in selected NHS and private centres in line with BAD guidance.

• Anti-inflammatory and antimalarial agents (e.g., topical or intralesional corticosteroids, doxycycline, hydroxychloroquine): Used in scarring alopecias such as lichen planopilaris and frontal fibrosing alopecia to slow progression.

• Systemic antifungals (e.g., griseofulvin, terbinafine): Required for tinea capitis; topical antifungals alone are insufficient.

• Anti-androgens for women (e.g., spironolactone, cyproterone acetate): Used off-label in selected women with androgenetic alopecia or hyperandrogenism under specialist supervision, with appropriate contraceptive precautions.

JAK inhibitors: Ritlecitinib (Litfulo) has received MHRA marketing authorisation for severe alopecia areata in adults and adolescents aged 12 years and over. Baricitinib (Olumiant) also holds an MHRA licence for severe alopecia areata in adults. NICE Technology Appraisal guidance determines NHS commissioning eligibility; patients should discuss current NHS availability and eligibility criteria with their dermatologist, as access pathways may vary. JAK inhibitors carry important risks including serious infections, reactivation of latent infections (including tuberculosis and herpes zoster), and thromboembolic events; regular monitoring is required during treatment.

Procedures with limited or variable evidence, such as platelet-rich plasma (PRP) therapy, low-level laser devices, and nutritional supplements, are available privately. Evidence for their effectiveness is currently limited or inconsistent; patients should discuss expected benefits, risks, and costs with a dermatologist before proceeding.

Hair transplant surgery is generally not available on the NHS and is considered a private treatment option for suitable candidates.

If you experience a suspected side effect from any medicine used for hair loss, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Experiencing these side effects? Our pharmacists can help you navigate them →

Further information: MHRA Drug Safety Update – Finasteride: risk of depression, suicidal thoughts and sexual dysfunction; SmPC (emc) – Finasteride 1 mg; SmPC (emc) – Minoxidil 5% cutaneous foam/solution; SmPC (emc) – Ritlecitinib (Litfulo); SmPC (emc) – Baricitinib (Olumiant); NICE Technology Appraisal – Ritlecitinib for severe alopecia areata; NHS – Hair transplant surgery; BAD clinical guidance on diphencyprone and scarring alopecias.

What to Expect at Your Dermatology Appointment

At a dermatology appointment for hair loss, you will undergo a detailed history, scalp examination with possible trichoscopy, and receive a management plan including investigations, treatment options, and follow-up arrangements.

Attending a dermatology appointment for hair loss can feel daunting, but understanding what to expect can help you prepare effectively and make the most of the consultation. Appointment length varies by clinic and the complexity of the case.

You will be asked a detailed history, which may include:

• Duration and progression of hair loss

• Family history of hair loss

• Recent illnesses, surgeries, or significant life stressors

• Medications you are currently taking (some drugs, including anticoagulants, retinoids, and certain antidepressants, are associated with hair shedding)

• Dietary habits and nutritional status

• Hair care practices, including heat styling, chemical treatments, and tight hairstyles

The dermatologist will then perform a physical examination of your scalp and hair, and may use a dermatoscope for closer assessment. They will explain their findings clearly and discuss the likely diagnosis with you.

If investigations are required, these will be arranged at the appointment or shortly afterwards. A management plan will be outlined, including any recommended treatments, lifestyle modifications, and follow-up arrangements.

To help make the most of your appointment, it is useful to:

• Bring a list of your current medications and any previous blood test results

• Bring photographs showing the progression of your hair loss over time, if available

• Avoid heavy styling products on the day, as these can make assessment of scalp condition more difficult

• Note any questions you wish to ask in advance

You are encouraged to raise any concerns about the psychological impact of hair loss, as this is a recognised and important aspect of care.

Further information: BAD – Find a dermatologist and patient resources.

Getting a Referral and Accessing Dermatology Services in the UK

NHS dermatology referrals for hair loss are made by your GP via the e-Referral Service; for urgent conditions such as suspected scarring alopecia, GPs can prioritise the referral, and private dermatology offers a faster alternative route.

In the UK, access to NHS dermatology services for hair loss typically begins with a consultation with your GP. Your GP will take an initial history, arrange baseline blood tests, and assess whether a specialist referral is clinically indicated. Referrals are made via the NHS e-Referral Service, and waiting times can vary significantly depending on your region and the clinical urgency of the referral.

For conditions where prompt treatment is important — such as suspected scarring alopecia or severe tinea capitis in a child — GPs can mark a referral as urgent where clinically indicated. It is worth discussing the urgency of your situation clearly with your GP to ensure the referral reflects the clinical need. Note that the two-week-wait pathway is reserved for suspected cancer and is not applicable to hair loss referrals.

If NHS waiting times are lengthy, private dermatology is an alternative route. Many consultant dermatologists work across both NHS and private practice. Private appointments can often be arranged more quickly, and some patients choose to begin private assessment before transitioning back to NHS care for ongoing treatment. Private consultation fees vary and change over time; contact individual clinics for current pricing.

When seeking a private dermatologist, it is advisable to verify that they are:

• Registered with the General Medical Council (GMC)

• A Fellow or Member of the British Association of Dermatologists (BAD)

• Experienced in the specific type of hair loss you are concerned about

The BAD website provides a searchable directory of accredited specialists. Regardless of the route taken, early assessment and accurate diagnosis remain the most important steps towards effective management of hair loss.

Further information: NHS – Referral to a specialist; BAD – Find a dermatologist directory.

Frequently Asked Questions